Shkreli Fallout Continues: PhRMA Seems To Soften Stance On REMS Legislation
This article was originally published in The Pink Sheet Daily
Executive Summary
Brand drug representative tells Senate subcommittee there are problems with bill that would make it easier for generics to obtain samples, but did not appear interested in scrapping it.